Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Child Nutrition Disorders | 3 | 2019 | 12 | 2.090 |
Why?
|
Nutritional Status | 8 | 2020 | 83 | 1.680 |
Why?
|
Malnutrition | 4 | 2018 | 34 | 1.430 |
Why?
|
Refeeding Syndrome | 2 | 2019 | 3 | 1.390 |
Why?
|
Anthropometry | 3 | 2019 | 74 | 1.390 |
Why?
|
Parenteral Nutrition | 6 | 2024 | 60 | 1.370 |
Why?
|
Nutrition Assessment | 3 | 2019 | 21 | 1.350 |
Why?
|
Enteral Nutrition | 7 | 2024 | 102 | 1.200 |
Why?
|
Micronutrients | 3 | 2019 | 17 | 1.190 |
Why?
|
Trace Elements | 3 | 2019 | 11 | 1.190 |
Why?
|
Infant | 18 | 2024 | 3036 | 1.150 |
Why?
|
Infant, Premature | 3 | 2024 | 287 | 1.120 |
Why?
|
Gastroenterology | 3 | 2020 | 134 | 0.980 |
Why?
|
Child | 26 | 2023 | 6913 | 0.950 |
Why?
|
Short Bowel Syndrome | 4 | 2017 | 37 | 0.900 |
Why?
|
Child, Preschool | 17 | 2023 | 3608 | 0.890 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2023 | 78 | 0.890 |
Why?
|
Cronobacter | 1 | 2022 | 1 | 0.880 |
Why?
|
Cronobacter sakazakii | 1 | 2022 | 2 | 0.880 |
Why?
|
Child Development | 3 | 2019 | 163 | 0.840 |
Why?
|
Hypophosphatemia | 2 | 2019 | 8 | 0.840 |
Why?
|
Selenium | 1 | 2021 | 44 | 0.810 |
Why?
|
Exocrine Pancreatic Insufficiency | 2 | 2019 | 8 | 0.780 |
Why?
|
Vitamins | 2 | 2019 | 81 | 0.780 |
Why?
|
Hyperglycemia | 2 | 2019 | 176 | 0.740 |
Why?
|
Intestinal Absorption | 3 | 2009 | 123 | 0.720 |
Why?
|
Fanconi Syndrome | 1 | 2018 | 3 | 0.660 |
Why?
|
Chromium | 1 | 2017 | 17 | 0.640 |
Why?
|
Glucose | 2 | 2018 | 637 | 0.640 |
Why?
|
Arm | 1 | 2018 | 91 | 0.620 |
Why?
|
Nutritional Support | 2 | 2017 | 17 | 0.610 |
Why?
|
Growth | 3 | 2001 | 43 | 0.580 |
Why?
|
Avitaminosis | 2 | 2019 | 5 | 0.550 |
Why?
|
Crohn Disease | 4 | 2022 | 729 | 0.520 |
Why?
|
Infant, Newborn | 7 | 2024 | 2369 | 0.510 |
Why?
|
Food, Formulated | 3 | 2022 | 24 | 0.500 |
Why?
|
Humans | 42 | 2024 | 86281 | 0.500 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 61 | 0.430 |
Why?
|
Mesalamine | 2 | 2005 | 88 | 0.420 |
Why?
|
Infant Formula | 3 | 2022 | 17 | 0.400 |
Why?
|
Failure to Thrive | 2 | 2002 | 17 | 0.400 |
Why?
|
Diarrhea | 2 | 2018 | 181 | 0.380 |
Why?
|
Choline Deficiency | 1 | 2010 | 4 | 0.370 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 241 | 0.370 |
Why?
|
Choline | 1 | 2010 | 23 | 0.370 |
Why?
|
Malabsorption Syndromes | 1 | 2009 | 21 | 0.360 |
Why?
|
Digestive System Diseases | 1 | 2009 | 18 | 0.360 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2021 | 52 | 0.360 |
Why?
|
Growth Disorders | 2 | 2019 | 63 | 0.350 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2009 | 7 | 0.350 |
Why?
|
Methylmalonic Acid | 1 | 2009 | 6 | 0.350 |
Why?
|
Electrolytes | 2 | 2019 | 52 | 0.350 |
Why?
|
Body Composition | 2 | 2018 | 68 | 0.340 |
Why?
|
Intestines | 2 | 2009 | 407 | 0.330 |
Why?
|
Energy Metabolism | 2 | 2019 | 271 | 0.310 |
Why?
|
Amino Acids | 3 | 2023 | 252 | 0.310 |
Why?
|
Reference Values | 2 | 2019 | 673 | 0.310 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 199 | 0.300 |
Why?
|
Probiotics | 1 | 2008 | 81 | 0.290 |
Why?
|
Adolescent | 13 | 2018 | 8968 | 0.290 |
Why?
|
Dietary Fats | 2 | 2019 | 134 | 0.280 |
Why?
|
Hypervitaminosis A | 1 | 2005 | 2 | 0.280 |
Why?
|
Vitamin A | 1 | 2005 | 27 | 0.270 |
Why?
|
Feces | 3 | 2019 | 316 | 0.260 |
Why?
|
Male | 20 | 2023 | 40860 | 0.260 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 1562 | 0.260 |
Why?
|
Rehydration Solutions | 1 | 2004 | 4 | 0.260 |
Why?
|
Dehydration | 1 | 2004 | 18 | 0.250 |
Why?
|
Dietary Supplements | 1 | 2005 | 128 | 0.250 |
Why?
|
Milk | 3 | 2020 | 53 | 0.250 |
Why?
|
Gastroenteritis | 1 | 2004 | 27 | 0.250 |
Why?
|
Fluid Therapy | 1 | 2004 | 50 | 0.240 |
Why?
|
Pneumonia | 1 | 2005 | 178 | 0.240 |
Why?
|
Pancreatic Elastase | 2 | 2019 | 15 | 0.230 |
Why?
|
Insulin | 2 | 2019 | 1159 | 0.230 |
Why?
|
Dietary Fiber | 1 | 2023 | 43 | 0.230 |
Why?
|
Female | 20 | 2023 | 44405 | 0.220 |
Why?
|
Endodermal Sinus Tumor | 1 | 2002 | 3 | 0.220 |
Why?
|
Constipation | 2 | 2023 | 63 | 0.210 |
Why?
|
Body Mass Index | 2 | 2018 | 770 | 0.210 |
Why?
|
Pelvic Neoplasms | 1 | 2002 | 45 | 0.210 |
Why?
|
Liver | 2 | 2023 | 1229 | 0.210 |
Why?
|
Teratoma | 1 | 2002 | 50 | 0.210 |
Why?
|
Powders | 1 | 2022 | 73 | 0.210 |
Why?
|
Pancreas | 2 | 2019 | 239 | 0.200 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2021 | 26 | 0.200 |
Why?
|
Societies | 1 | 2020 | 12 | 0.190 |
Why?
|
Retrospective Studies | 6 | 2021 | 8431 | 0.190 |
Why?
|
Body Weight | 3 | 2013 | 459 | 0.190 |
Why?
|
Vitamin D | 1 | 2002 | 261 | 0.190 |
Why?
|
Steatorrhea | 1 | 2019 | 2 | 0.180 |
Why?
|
Enzyme Replacement Therapy | 1 | 2019 | 2 | 0.180 |
Why?
|
Trypsinogen | 1 | 2019 | 4 | 0.180 |
Why?
|
Nutritional Requirements | 2 | 2013 | 17 | 0.180 |
Why?
|
Magnesium Deficiency | 1 | 2019 | 5 | 0.180 |
Why?
|
Ectodermal Dysplasia | 1 | 2019 | 2 | 0.180 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 6 | 0.180 |
Why?
|
Pancreatic Function Tests | 1 | 2019 | 7 | 0.180 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2019 | 8 | 0.180 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2022 | 546 | 0.180 |
Why?
|
Rest | 1 | 2000 | 48 | 0.180 |
Why?
|
Thiamine Deficiency | 1 | 2019 | 4 | 0.180 |
Why?
|
Chymotrypsin | 1 | 2019 | 28 | 0.180 |
Why?
|
Anus, Imperforate | 1 | 2019 | 11 | 0.180 |
Why?
|
Hypokalemia | 1 | 2019 | 29 | 0.180 |
Why?
|
Mitochondrial Diseases | 1 | 2019 | 10 | 0.180 |
Why?
|
Starvation | 1 | 2019 | 23 | 0.180 |
Why?
|
Pancreatic Diseases | 1 | 2019 | 52 | 0.180 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2019 | 46 | 0.180 |
Why?
|
Pain | 1 | 2002 | 389 | 0.180 |
Why?
|
Muscular Diseases | 1 | 2019 | 63 | 0.170 |
Why?
|
Pancreatitis, Chronic | 1 | 2019 | 49 | 0.170 |
Why?
|
Nose | 1 | 2019 | 94 | 0.170 |
Why?
|
Cerebral Palsy | 1 | 2019 | 90 | 0.170 |
Why?
|
Disability Evaluation | 1 | 2019 | 136 | 0.170 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 1998 | 8 | 0.170 |
Why?
|
Enema | 1 | 1998 | 37 | 0.170 |
Why?
|
Cystic Fibrosis | 1 | 2019 | 112 | 0.170 |
Why?
|
Pericarditis | 1 | 1998 | 13 | 0.170 |
Why?
|
Physical Examination | 1 | 2019 | 149 | 0.170 |
Why?
|
Intestinal Perforation | 1 | 1998 | 34 | 0.170 |
Why?
|
Aminoglycosides | 1 | 2018 | 32 | 0.170 |
Why?
|
Drug Hypersensitivity | 1 | 1998 | 37 | 0.170 |
Why?
|
Intellectual Disability | 1 | 2019 | 185 | 0.160 |
Why?
|
Sodium | 1 | 2019 | 340 | 0.160 |
Why?
|
Colitis, Ulcerative | 2 | 2022 | 708 | 0.160 |
Why?
|
Diet | 2 | 2019 | 442 | 0.160 |
Why?
|
Urinalysis | 1 | 2018 | 33 | 0.160 |
Why?
|
Aging | 1 | 2002 | 689 | 0.160 |
Why?
|
Celiac Disease | 1 | 2001 | 202 | 0.160 |
Why?
|
Metabolic Diseases | 1 | 2018 | 48 | 0.160 |
Why?
|
Hypothyroidism | 1 | 2019 | 232 | 0.160 |
Why?
|
World Health Organization | 1 | 2018 | 103 | 0.160 |
Why?
|
Osteoporosis | 1 | 1999 | 121 | 0.150 |
Why?
|
Program Development | 1 | 2017 | 124 | 0.150 |
Why?
|
United States | 4 | 2024 | 6637 | 0.140 |
Why?
|
Clostridium Infections | 1 | 2018 | 125 | 0.140 |
Why?
|
Milk Proteins | 1 | 2016 | 24 | 0.140 |
Why?
|
Milk Hypersensitivity | 1 | 2016 | 10 | 0.140 |
Why?
|
Esophagitis | 2 | 2006 | 42 | 0.130 |
Why?
|
Disease Management | 1 | 2017 | 327 | 0.130 |
Why?
|
Patient Care Team | 1 | 2017 | 280 | 0.130 |
Why?
|
Eosinophilia | 2 | 2006 | 83 | 0.130 |
Why?
|
Birth Weight | 2 | 2016 | 144 | 0.120 |
Why?
|
Interleukin-12 Receptor beta 1 Subunit | 1 | 2013 | 2 | 0.120 |
Why?
|
Candidiasis | 1 | 2013 | 36 | 0.120 |
Why?
|
Blood Glucose | 1 | 2017 | 873 | 0.120 |
Why?
|
Dietary Proteins | 1 | 2013 | 30 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 739 | 0.110 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 38 | 0.110 |
Why?
|
Risk Factors | 2 | 2019 | 5397 | 0.110 |
Why?
|
HIV Infections | 1 | 2001 | 768 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 1030 | 0.110 |
Why?
|
Eosinophilic Esophagitis | 1 | 2011 | 18 | 0.100 |
Why?
|
Food | 1 | 2011 | 85 | 0.100 |
Why?
|
Antigens | 1 | 2011 | 228 | 0.090 |
Why?
|
Body Height | 2 | 2000 | 99 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2009 | 66 | 0.090 |
Why?
|
Acidosis | 1 | 2009 | 55 | 0.090 |
Why?
|
Drug Interactions | 1 | 2009 | 248 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 916 | 0.080 |
Why?
|
Bacterial Translocation | 1 | 2008 | 25 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2009 | 145 | 0.080 |
Why?
|
Cattle | 2 | 2020 | 374 | 0.080 |
Why?
|
Prevalence | 2 | 2002 | 1239 | 0.080 |
Why?
|
Recurrence | 3 | 2013 | 1137 | 0.080 |
Why?
|
Placebos | 1 | 2008 | 218 | 0.080 |
Why?
|
Animals | 4 | 2020 | 26518 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2008 | 399 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2001 | 1610 | 0.070 |
Why?
|
Age Factors | 1 | 2010 | 1842 | 0.070 |
Why?
|
Adult | 5 | 2013 | 25577 | 0.060 |
Why?
|
Osmolar Concentration | 1 | 2004 | 181 | 0.060 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 73 | 0.060 |
Why?
|
Galactans | 1 | 2023 | 1 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2008 | 1822 | 0.060 |
Why?
|
African Americans | 1 | 2002 | 10 | 0.060 |
Why?
|
Menarche | 1 | 2022 | 24 | 0.060 |
Why?
|
Sacrococcygeal Region | 1 | 2002 | 9 | 0.050 |
Why?
|
Gastrointestinal Tract | 1 | 2004 | 191 | 0.050 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2002 | 12 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2002 | 103 | 0.050 |
Why?
|
Anal Canal | 1 | 2002 | 89 | 0.050 |
Why?
|
Seasons | 1 | 2002 | 223 | 0.050 |
Why?
|
Perinatology | 1 | 2001 | 14 | 0.050 |
Why?
|
Peptides | 1 | 2004 | 639 | 0.050 |
Why?
|
Beverages | 1 | 2020 | 17 | 0.050 |
Why?
|
Age Determination by Skeleton | 1 | 2000 | 12 | 0.050 |
Why?
|
Milk, Human | 1 | 2020 | 43 | 0.050 |
Why?
|
Puberty | 1 | 2000 | 59 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2002 | 347 | 0.050 |
Why?
|
Medical Records | 1 | 2000 | 119 | 0.050 |
Why?
|
Cohort Studies | 2 | 2011 | 2759 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2000 | 99 | 0.050 |
Why?
|
Health Education | 1 | 2020 | 100 | 0.050 |
Why?
|
Postoperative Period | 1 | 2000 | 303 | 0.040 |
Why?
|
Universities | 1 | 2020 | 135 | 0.040 |
Why?
|
Diphosphonates | 1 | 1999 | 36 | 0.040 |
Why?
|
Abdomen, Acute | 1 | 1998 | 20 | 0.040 |
Why?
|
Sulfasalazine | 1 | 1998 | 34 | 0.040 |
Why?
|
Fatal Outcome | 1 | 1998 | 293 | 0.040 |
Why?
|
Prednisone | 1 | 1998 | 255 | 0.040 |
Why?
|
Bone Density | 1 | 1999 | 209 | 0.040 |
Why?
|
North America | 1 | 2017 | 179 | 0.040 |
Why?
|
Sex Factors | 1 | 2000 | 1053 | 0.040 |
Why?
|
Administration, Oral | 1 | 2018 | 683 | 0.040 |
Why?
|
Societies, Medical | 1 | 2020 | 572 | 0.040 |
Why?
|
Protein Hydrolysates | 1 | 2016 | 9 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2005 | 2594 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2000 | 1671 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2000 | 2699 | 0.030 |
Why?
|
Patient Outcome Assessment | 1 | 2013 | 83 | 0.030 |
Why?
|
Surveys and Questionnaires | 1 | 2020 | 2495 | 0.030 |
Why?
|
Seafood | 1 | 2011 | 10 | 0.030 |
Why?
|
Eggs | 1 | 2011 | 12 | 0.030 |
Why?
|
Antigens, Plant | 1 | 2011 | 14 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2011 | 83 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 7949 | 0.020 |
Why?
|
Esophagus | 1 | 2011 | 102 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 722 | 0.020 |
Why?
|
Biopsy | 1 | 2011 | 1160 | 0.020 |
Why?
|
Patient Compliance | 1 | 2006 | 226 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2004 | 87 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 2004 | 117 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 1752 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2006 | 3616 | 0.010 |
Why?
|
Middle Aged | 1 | 2013 | 24957 | 0.010 |
Why?
|